# CLBT — Cellebrite DI Ltd. · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** CLBT  
**Sources:** 26  
**Published:** 2026-09-16  
**Canonical:** https://app.k3vl4r.com/research/deep-research-clbt-cellebrite-di-ltd-catalysts-narrative-risks-3915

---

## Snapshot (as of 2026-11-15)

Cellebrite DI Ltd. (Nasdaq: CLBT), an Israeli digital-forensics firm headquartered in Petah Tikva, closed at US$11.53 on November 13, 2026, with a market capitalization near US$2.9 billion [[12]](https://www.ad-hoc-news.de/boerse/news/nebenwerte/cellebrite-stock-holds-at-usd-11-62-as-2026-targets-stay-intact/70160936), [[17]](https://finance.yahoo.com/quote/CLBT/news/), [[18]](https://www.fool.com/quote/nasdaq/clbt/). The stock has been highly volatile: down 36.05% year-to-date and 40.2% over one year, though up 44.85% over three years [[18]](https://www.fool.com/quote/nasdaq/clbt/). It trades within a 52-week range of US$9.58 to US$19.98 [[12]](https://www.ad-hoc-news.de/boerse/news/nebenwerte/cellebrite-stock-holds-at-usd-11-62-as-2026-targets-stay-intact/70160936).

## Key Recent Catalysts (roughly August–November 2026)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-clbt-cellebrite-di-ltd-catalysts-narrative-risks-3915 (free to sign up)._
